For research use only. Not for therapeutic Use.
Conivaptan HCl is an orally active, non-peptide, vasopressin V1A and V2 receptor antagonist, used in the treatment of euvolemic and hypervolemic hyponatremia.<br>Conivaptan (0.03, 0.1 and 0.3 mg/kg i.v.) dose-dependently increases urine volume and reduces urine osmolality in both myocardial infarction and sham-operated rats. Conivaptan (0.3 mg/kg i.v.) significantly reduces right ventricular systolic pressure, left ventricular end-diastolic pressure, lung/body weight and right atrial pressure in myocardial infarction rats. Conivaptan (0.3 mg/kg i.v.) significantly increases dP/dt(max)/left ventricular pressure in myocardial infarction rats.
Catalog Number | A001205 |
CAS Number | 168626-94-6 |
Synonyms | NA |
Molecular Formula | C32H26N4O2.HCl |
Purity | ≥95% |
Target | Vasopressin Receptor |
Solubility | >14.8mg/mL in DMSO |
Storage | 3 years -20C powder |